These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 1919659

  • 1. Intensive chemotherapy with cisplatin, mitoxantrone, methotrexate and vincristine in metastatic breast cancer.
    Queirolo P, Repetto L, Gardin G, Miglietta L, Guido T, Pronzato P, Rosso R.
    J Chemother; 1991 Jun; 3(3):194-7. PubMed ID: 1919659
    [Abstract] [Full Text] [Related]

  • 2. Induction chemotherapy of dibromodulcitol, Adriamycin, vincristine, tamoxifen, and Halotestin with methotrexate in metastatic breast cancer: an Eastern Cooperative Oncology Group Study (E1181).
    Chang AY, Putt M, Pandya KJ, Harris J, Gelman R, Tormey DC, Falkson G.
    Am J Clin Oncol; 1998 Feb; 21(1):99-104. PubMed ID: 9499270
    [Abstract] [Full Text] [Related]

  • 3. MMM (mitomycin/mitoxantrone/methotrexate): an effective new regimen in the treatment of metastatic breast cancer.
    Smith IE, Powles TJ.
    Oncology; 1993 Apr; 50 Suppl 1():9-15. PubMed ID: 8483562
    [Abstract] [Full Text] [Related]

  • 4. First-line combination chemotherapy with mitoxantrone, methotrexate, vincristine and carboplatin (MIMOC) in advanced breast cancer.
    Bafaloukos D, Samonis G, Klinaki A, Daliani D, Karvounis N, Bacoyiannis C, Karabelis A, Milonakis N, Kosmidis P.
    Eur J Cancer; 1993 Apr; 29A(6):851-3. PubMed ID: 8484975
    [Abstract] [Full Text] [Related]

  • 5. First-line chemotherapy of advanced breast cancer with a combination of mitoxantrone, methotrexate, and vincristine (MIMO).
    Samonis G, Bafaloukos D, Margioris AN, Katsarma G, Toloudis P, Bacoyannis C, Karvounis N, Georgoulias V, Kosmidis P.
    Oncology; 1997 Apr; 54(5):371-5. PubMed ID: 9260597
    [Abstract] [Full Text] [Related]

  • 6. First-line treatment with mitoxantrone, methotrexate, vincristine, and carboplatine (MIMOC) plus cyclical hormonotherapy with tamoxifen and megestrol acetate in advanced breast cancer.
    Kakolyris S, Samonis G, Koukourakis M, Vlachonicolis J, Kalbakis K, Agelaki S, Chalkiadakis G, Sanidas E, Tsiftsis D, Georgoulias V.
    Am J Clin Oncol; 1999 Jun; 22(3):273-7. PubMed ID: 10362335
    [Abstract] [Full Text] [Related]

  • 7. Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial.
    Hainsworth JD, Jolivet J, Birch R, Hopkins LG, Greco FA.
    Cancer; 1997 Feb 15; 79(4):740-8. PubMed ID: 9024712
    [Abstract] [Full Text] [Related]

  • 8. Mitoxantrone dose augmentation utilizing filgrastim support in combination with fixed-dose 5-fluorouracil and leucovorin in women with metastatic breast cancer.
    Ingle JN, Kardinal CG, Suman VJ, Veeder MH, Schaefer PL, Kirschling RJ, Mailliard JA.
    Breast Cancer Res Treat; 1997 May 15; 43(3):193-200. PubMed ID: 9150898
    [Abstract] [Full Text] [Related]

  • 9. Chemotherapy with methotrexate, carboplatin, mitoxantrone (Novantrone) and vincristine (Oncovin) in transitional-cell urothelial cancer.
    Pectasides D, Mylonakis A, Antoniou F, Kostopoulou M, Triantaphyllis D, Papadopoulou M, Varthalitis J, Dimitriadis M, Athanassiou A.
    Oncology; 1998 May 15; 55(2):139-44. PubMed ID: 9499188
    [Abstract] [Full Text] [Related]

  • 10. Combination chemotherapy with methotrexate, bleomycin, and vincristine with or without cisplatin in advanced squamous cell carcinoma of the head and neck.
    Clavel M, Cognetti F, Dodion P, Wildiers J, Rosso R, Rossi A, Gignoux B, Van Rymenant M, Cortes-Funes H, Dalesio O.
    Cancer; 1987 Sep 15; 60(6):1173-7. PubMed ID: 2441836
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Low-dose mitomycin and weekly low-dose doxorubicin combination chemotherapy for patients with metastatic breast carcinoma previously treated with cyclophosphamide, methotrexate, and 5-fluorouracil.
    Colozza M, Tonato M, Grignani F, Davis S.
    Cancer; 1988 Jul 15; 62(2):262-5. PubMed ID: 3383126
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Phase II study of weekly mitoxantrone, 5-fluorouracil, and leucovorin in metastatic breast cancer.
    Repetto L, Miglietta L, Gardin G, Lanfranco C, Naso C, Merlini L, Giudici S, Venturino A, Campora E, Testore F.
    Breast Cancer Res Treat; 1994 Jul 15; 30(2):133-7. PubMed ID: 7949211
    [Abstract] [Full Text] [Related]

  • 17. Four-step high-dose sequential chemotherapy with double hematopoietic progenitor-cell rescue for metastatic breast cancer.
    Patrone F, Ballestrero A, Ferrando F, Brema F, Moraglio L, Valbonesi M, Basta P, Ghio R, Gobbi M, Sessarego M.
    J Clin Oncol; 1995 Apr 15; 13(4):840-6. PubMed ID: 7707109
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prednimustine combined with mitoxantrone and 5-fluorouracil for first and second-line chemotherapy in advanced breast cancer.
    Samonigg H, Stöger H, Kasparek AK, Schmid M, Dusleag J, Pfeiffer K, Smola M, Steindorfer P, Lechner P.
    Cancer Chemother Pharmacol; 1991 Apr 15; 27(6):477-80. PubMed ID: 2013118
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.